Delivery Order SPE2DB22D2214-SPE2DB25FS5XT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Triamterene-HCTZ 37.5-25 mg tablets in a quantity of 500 units, with a ceiling value of $1,267.99. This is a firm fixed-price delivery order with an ultimate completion date of August 8, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,730.63 to AmerisourceBergen Drug Corp for the supply of Triamterene-HCTZ 37.5-25 mg tablets in quantities of 500 units. This non-set-aside, firm fixed-price delivery order was competitively awarded on August 8, 2025, with an ultimate completion date of August 11, 2025. The medication will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,347.67 on August 19, 2025, for the supply of Triamterene-HCTZ 75-50 mg tablets in quantities of 500 units. This competitively awarded, firm fixed-price contract is scheduled for completion by August 20, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,299.60 firm fixed price delivery order is for the supply of Triamterene-HCTZ 37.5-25 mg tablets in 500-count packages. The contract has an ultimate completion date of September 20, 2024 and does not utilize any set-asides. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,668.35 firm fixed-price delivery order is for the supply of TRIAMTERENE-HCTZ 37.5-25 MG TB 500S, a cardiovascular medication. The contract has an ultimate completion date of December 3, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,235.12 firm fixed price contract is for the delivery of Triamterene-HCTZ 37.5-25 mg tablets in 500-count bottles. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, valued at $2,135.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of TRIAMTERENE-HCTZ 37.5-25 MG TB 500S, a generic pharmaceutical product, with a period of performance through December 9, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Triamterene-HCTZ 37.5-25 mg tablets, a generic medication used to treat high blood pressure and fluid retention. The contract has a ceiling value of $7,576.63 and a completion date of March 5, 2024. It is a firm fixed-price contract, with no set-aside...
- This is a $2,594.59 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide TRIAMTERENE-HCTZ 37.5-25 MG TB 500S, a pharmaceutical product. The contract has an ultimate completion date of July 1, 2025. AmerisourceBergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including a $999,999,999.00...
- This delivery order for $725.76 was awarded by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corp for the supply of 100 tablets of the pharmaceutical TRIAMTERENE-HCTZ 37.5-25 MG. The place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania, and all supplies must be delivered between September 8-11, 2023. The contract utilizes firm fixed pricing and has no set-aside designation. As the Defense Logistics Agency is responsible for...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS5XTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,085.19 to AmerisourceBergen Drug Corp for 500 tablets of Triamterene-HCTZ 37.5-25 mg, a generic combination diuretic medication commonly used in the treatment of hypertension. Awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, this firm fixed price delivery order represents a routine pharmaceutical procurement under a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies supporting military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The award reflects AmerisourceBergen's established capability to compete and perform under DLA's pharmaceutical supply requirements, with the company supporting both routine medical procurement and specialized healthcare commodities across multiple therapeutic domains for federal military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/25/25 |